Cencora raises FY25 adjusted EPS view to $15.15-$15.45 from $14.80-$15.10

Consensus for FY25 EPS is $14.98. Increased FY25 EPS guidance reflects the expected contribution from the closing of the RCA acquisition and also continued momentum in the U.S. Healthcare Solutions reportable segment.